Keywords
Depressive Disorder, Major ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

187 Search results.

Levomilnacipran Extended Release in Major Depression NCT02288325 - Eligibility Criteria

- 4/15/19 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Multicenter, Relapse Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder; ODM derived from: https://clinicaltrials.gov/show/NCT02288325

Eligibility Depressive Disorder, Major NCT02067299

- 3/17/19 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study to Investigate the Effect of JNJ-42847922 on Polysomnography Measures in Patients With Major Depressive Disorder With Insomnia Who Are Stably Treated With Antidepressants; ODM derived from: https://clinicaltrials.gov/show/NCT02067299

Eligibility Depressive Disorder, Major NCT02473289

- 3/17/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder; ODM derived from: https://clinicaltrials.gov/show/NCT02473289

Eligibility Unipolar Major Depressive Disorder NCT01875419

- 1/19/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Non-invasive Brain Stimulation and Cognitive Processing in Depression; ODM derived from: https://clinicaltrials.gov/show/NCT01875419

Eligibility Major Depressive Disorder NCT01608399

- 1/17/19 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Clinical Trial of the Effectiveness of Metacognitive Therapy in the Treatment of Patients With Major Depressive Disorder; ODM derived from: https://clinicaltrials.gov/show/NCT01608399

Eligibility Major Depression NCT01788657

- 1/17/19 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
iCBT for Depression - Standard Versus Condensed Treatment Material; ODM derived from: https://clinicaltrials.gov/show/NCT01788657

Eligibility Major Depression NCT01034995

- 1/17/19 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder; ODM derived from: https://clinicaltrials.gov/show/NCT01034995

Eligibility Major Depression in Remission NCT02407652

- 1/17/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Cognitive Control Training for Remitted Depressed Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02407652

Eligibility Major Depressive Disorder NCT02191124

- 1/6/19 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled Trial; ODM derived from: https://clinicaltrials.gov/show/NCT02191124

Eligibility Major Depressive Disorder NCT02051413

- 1/5/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN); ODM derived from: https://clinicaltrials.gov/show/NCT02051413

Eligibility Major Depressive Disorder NCT01995422

- 1/5/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Effect of Physical Activity on Depressive Symptoms With a 5 Month Follow-up; ODM derived from: https://clinicaltrials.gov/show/NCT01995422

Eligibility Major Depressive Disorder NCT01724112

- 1/5/19 - 1 form, 2 itemgroups, 8 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD); ODM derived from: https://clinicaltrials.gov/show/NCT01724112